Synergy Pharma gets court OK to sell assets to Bausch; shares +4.7% [Seeking Alpha]
SYNERGY PHARMACEUTICALS (SGYP)
Last synergy pharmaceuticals earnings: 11/8 05:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.synergypharma.com
Company Research
Source: Seeking Alpha
Synergy Pharma gets court OK to sell assets to Bausch; shares +4.7% Synergy Pharmaceuticals (NASDAQ: SGYP gotten court approval BHC That includes all rights to Trulance (plecanatide), dolcanatide and related intellectual property. The sale's now expected to close on or about March 5. Bausch agreed to acquire the assets Synergy is up 4.7%
Show less
Read more
Impact Snapshot
Event Time:
SGYP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
SGYP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
SGYP alerts
High impacting SYNERGY PHARMACEUTICALS news events
Weekly update
A roundup of the hottest topics